American International Group’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-14,103
| Closed | -$88.1K | – | 3210 |
|
2023
Q1 | $88.1K | Buy |
14,103
+281
| +2% | +$1.76K | ﹤0.01% | 2521 |
|
2022
Q4 | $84.3K | Sell |
13,822
-50
| -0.4% | -$305 | ﹤0.01% | 2585 |
|
2022
Q3 | $166K | Buy |
13,872
+195
| +1% | +$2.33K | ﹤0.01% | 2265 |
|
2022
Q2 | $172K | Buy |
13,677
+899
| +7% | +$11.3K | ﹤0.01% | 2288 |
|
2022
Q1 | $144K | Sell |
12,778
-900
| -7% | -$10.1K | ﹤0.01% | 2433 |
|
2021
Q4 | $242K | Sell |
13,678
-409
| -3% | -$7.24K | ﹤0.01% | 2260 |
|
2021
Q3 | $324K | Buy |
14,087
+6,489
| +85% | +$149K | ﹤0.01% | 2129 |
|
2021
Q2 | $177 | Sell |
7,598
-279
| -4% | -$6 | ﹤0.01% | 2587 |
|
2021
Q1 | $245 | Buy |
+7,877
| New | +$245 | ﹤0.01% | 2264 |
|